Cargando…
Editorial: Cannabinoids as potential treatment for neurological diseases
Autores principales: | Gómez-Cañas, María, Morales, Paula, Satta, Valentina, Rodríguez-Cueto, Carmen, García, Concepción, Sagredo, Onintza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9808380/ https://www.ncbi.nlm.nih.gov/pubmed/36605545 http://dx.doi.org/10.3389/fnins.2022.1108101 |
Ejemplares similares
-
Neuropathological Characterization of a Dravet Syndrome Knock-In Mouse Model Useful for Investigating Cannabinoid Treatments
por: Satta, Valentina, et al.
Publicado: (2021) -
Targeting Cannabinoid CB(2) Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
por: Navarro, Gemma, et al.
Publicado: (2016) -
Editorial: Challenges and Conundrums in Cannabinoid-Based Treatments for Epilepsy Syndromes and Associated Neurobehavioral Comorbidities
por: Gómez-Nieto, Ricardo, et al.
Publicado: (2021) -
Cannabinoid Ligands Targeting TRP Channels
por: Muller, Chanté, et al.
Publicado: (2019) -
Development of An Oral Treatment with the PPAR-γ-Acting Cannabinoid VCE-003.2 Against the Inflammation-Driven Neuronal Deterioration in Experimental Parkinson’s Disease
por: Burgaz, Sonia, et al.
Publicado: (2019)